Xlife Sciences AG
Develops and commercializes early-stage life sciences research projects.
XLS | SW
Overview
Corporate Details
- ISIN(s):
- CH0461929603 (+1 more)
- LEI:
- 984500AH590BE88BB517
- Country:
- Switzerland
- Address:
- Talacker 35, 8001 Zürich
Description
Xlife Sciences AG is a life sciences company that specializes in the value development and commercialization of early-stage research projects. The company identifies promising technologies from universities and other research institutions, acting as an incubator and accelerator to bridge the gap between academic research and healthcare markets. Its operations are focused on four core areas: technology platforms, biotechnologies and therapies, medical technology (health technology), and the application of artificial intelligence in life sciences and digital health. The primary objective is to develop solutions that address high unmet medical needs and improve quality of life.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2022-09-26 02:00 |
Projektgesellschaft Laxxon Medical erreicht wichtigen Meilenstein
|
German | HTML • 9.5 KB | ||
| 2022-09-21 07:00 |
Xlife Sciences strengthens sustainability activities with ESG strategy
|
English | HTML • 12.9 KB | ||
| 2022-09-21 02:00 |
Xlife Sciences strengthens sustainability activities with ESG strategy
|
English | HTML • 11.2 KB | ||
| 2022-09-21 02:00 |
Xlife Sciences verstärkt Nachhaltigkeits-Aktivitäten mit ESG-Strategie
|
German | HTML • 12.7 KB | ||
| 2022-09-15 07:00 |
Baader Bank initiates research coverage on Xlife Sciences
|
English | HTML • 10.5 KB | ||
| 2022-08-22 07:00 |
Intron Health initiates research coverage of Xlife Sciences
|
English | HTML • 9.3 KB | ||
| 2022-07-04 07:01 |
FUSE-AI supports German pharmacies in digitization
|
English | HTML • 11.9 KB | ||
| 2022-07-04 02:00 |
FUSE-AI supports German pharmacies in digitization
|
English | HTML • 10.2 KB | ||
| 2022-07-04 02:00 |
FUSE-AI unterstützt deutsche Apotheken in der Digitalisierung
|
German | HTML • 10.5 KB | ||
| 2022-05-16 07:05 |
Project company Xsight Optics successfully participates in start-up competition…
|
English | HTML • 10.0 KB | ||
| 2022-05-09 07:00 |
Xlife Sciences: First Valuation Report confirms substancial potential of the pr…
|
English | HTML • 9.0 KB | ||
| 2022-04-29 23:38 |
Xlife Sciences publishes annual results 2021 and outlook 2022
|
English | HTML • 16.8 KB | ||
| 2022-04-25 07:01 |
License partner of Xlife Sciences announces successful completion of phase 1 of…
|
English | HTML • 10.8 KB | ||
| 2022-04-21 07:01 |
Xlife Sciences: Date of publication Annual Report 2022
|
English | HTML • 7.3 KB | ||
| 2022-02-11 07:13 |
Xlife Sciences AG: Xlife Sciences' shares begin trading on SIX Swiss Exchange
|
English | HTML • 10.4 KB |
Automate Your Workflow. Get a real-time feed of all Xlife Sciences AG filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Xlife Sciences AG
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Xlife Sciences AG via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2022-06-15 | N/A | Executive member | Buy | None | 6,000.00 CHF |
| 2022-06-15 | N/A | Executive member | Buy | None | 3,000.00 CHF |
| 2022-06-14 | N/A | Executive member | Buy | None | 15,500.00 CHF |
| 2022-06-10 | N/A | Executive member | Buy | None | 6,728.90 CHF |
| 2022-06-07 | N/A | Executive member | Buy | None | 34,800.00 CHF |
| 2022-06-03 | N/A | Executive member | Buy | None | 3,540.00 CHF |
| 2022-05-24 | N/A | Executive member | Buy | None | 3,400.00 CHF |
| 2022-05-17 | N/A | Executive member | Buy | None | 10,794.20 CHF |
| 2022-05-13 | N/A | Executive member | Buy | None | 3,690.00 CHF |
| 2022-05-10 | N/A | Executive member | Buy | None | 1,935.00 CHF |
Peer Companies
